<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01149577</url>
  </required_header>
  <id_info>
    <org_study_id>SCHOLZ0003</org_study_id>
    <nct_id>NCT01149577</nct_id>
  </id_info>
  <brief_title>Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Institute of Psychiatry, Ranchi, India</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Institute of Psychiatry, Ranchi, India</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute and sub-chronic administration of olanzapine has shown a favourable effect on the sleep
      disturbances in previously medicated schizophrenia patients with predominantly negative
      symptoms. The present study will be carried out to clarify the effect of olanzapine on
      polysomnographic profiles of schizophrenia patients in an acute phase of illness after
      controlling for the drug effects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty schizophrenia patients (11 drug naïve and 9 drug free) will be studied over a period
      of six weeks of olanzapine treatment. Patients will be assessed at the baseline on BPRS,
      PANSS, CDSS and UKU side effect rating scales and a baseline 40 channels polysomnography will
      be done. After the initial assessment, patients will put on olanzapine treatment, in flexible
      dosages based on clinical response, for a period of six weeks when a final assessment on
      clinical rating scales and polysomnography will be done. The sleep data will be scored
      manually for staging based on Rechtschaffen and Kales criteria.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep EEG</measure>
    <time_frame>06 weeks</time_frame>
    <description>Changes in Sleep EEG parameters like Total sleep time, total sleep period, sleep efficiency, sleep latency, stage shifts, stage 1 shifts, stage 1 parameters, stage 2 parameters, stage 3 parameters, stage 4 parameters, rapid eye movement (REM) parameters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychopathology</measure>
    <time_frame>06 weeks</time_frame>
    <description>Changes in psychopathological scores as measured by Brief Psychiatric Rating Scale (BPRS) and Positive and Negative Syndrome Scale (PANSS).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Schizophrenia patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study population of 25 schizophrenia patients constituted the active arm of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Olanzapine</intervention_name>
    <description>06 weeks treatment with Olanzapine in a flexible dosage schedule.</description>
    <arm_group_label>Schizophrenia patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male patients fulfilling International Classification of Diseases-10 Diagnostic
             Criteria for Research for schizophrenia

          2. Aged 18-50 Yrs

          3. Drug naïve or drug free (not receiving any psychotropic medication for the past 4
             months)

          4. Consenting

        Exclusion Criteria:

          1. Any comorbid psychiatric illness

          2. Significant medical or neurological illness

          3. History of significant head injury, epilepsy

          4. Substance use in the past 4 months excluding nicotine and caffeine

          5. Presence of a primary sleep disorder
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammad Zia Ul Haq Katshu, DPM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Institute of Psychiatry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Institute of Psychiatry</name>
      <address>
        <city>Ranchi</city>
        <state>Jharkhand</state>
        <zip>834006</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2010</study_first_submitted>
  <study_first_submitted_qc>June 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2010</study_first_posted>
  <last_update_submitted>June 22, 2010</last_update_submitted>
  <last_update_submitted_qc>June 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 23, 2010</last_update_posted>
  <responsible_party>
    <name_title>S Haque Nizamie</name_title>
    <organization>Central Institute of Psychiatry</organization>
  </responsible_party>
  <keyword>Olanzapine</keyword>
  <keyword>Schizophrenia</keyword>
  <keyword>Polysomnography</keyword>
  <keyword>Slow wave sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olanzapine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

